Insider · CIK 0001873352
Salek-Ardakani Shahram
Reports to the SEC for 1 company · LA JOLLA, CA
Transactions
1
Companies
1
Filings
1
CIK
0001873352
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2022-01-03 | JANXJanux Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
Recent filings
- 4Salek-Ardakani Shahram0001209191-22-001833SEC(opens sec.gov)
Companies
Address
C/O JANUX THERAPEUTICS, INC. 11099 N. TORREY PINES ROAD, SUITE 290
LA JOLLA, CA, 92037